Uncategorized

AstraZeneca’s win in lung cancer; Sandoz inks a China deal

A combination of AstraZeneca’s Tagrisso and Hutchmed’s Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight started seeking a partner for its autism drug.

​Read More

Published

on

A combination of AstraZeneca’s Tagrisso and Hutchmed’s Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight started seeking a partner for its autism drug.

​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version